ClinicalTrials.Veeva

Menu

Pre-ROSC Intra-Nasal Cooling Effectiveness (PRINCE)

B

BeneChill

Status

Completed

Conditions

Cardiac Arrest

Treatments

Device: RhinoChill
Other: Control

Study type

Interventional

Funder types

Industry

Identifiers

NCT00808236
BC-CP1012

Details and patient eligibility

About

The purpose of the study was to demonstrate the safety and feasibility of early intranasal cooling prior to return of spontaneous circulation (ROSC) in the emergency medical services (EMS) environment. It was hypothesized that cooling during the resuscitation attempt would increase ROSC and subsequent survival. The study was not powered to demonstrate statistically-significant differences in any outcome parameter, but was intended as an exploratory study only.

Full description

Out of hospital cardiac arrest remains a significant cause of death. Mild hypothermia induced after resuscitation from cardiac arrest has been shown to improve neurologically intact survival. Studies in dogs and rodents have demonstrated improved outcomes when cooling is initiated intra-arrest.

The RhinoChill is a non-invasive cooling device through which rapid cooling is achieved via the intranasal delivery of an evaporative coolant into the nasopharynx. Due to its non-invasive and portable nature, the RhinoChill can be used to begin cooling earlier than other cooling devices.

Studies performed using the RhinoChill in a porcine model of cardiac arrest suggest that cooling with the RhinoChill prior to the first defibrillation attempt facilitates resuscitation and improves resuscitation rate and neurologically intact survival.

This study is being performed to assess the feasibility of using the RhinoChill device in the pre-hospital setting to improve resuscitation from cardiac arrest.

Enrollment

200 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ≥18 years
  • Collapse was witnessed
  • No pulse
  • Unresponsive to external stimuli

Exclusion criteria

  • Have an etiology of cardiac arrest due to trauma, severe bleeding, drug overdose (OD), cerebrovascular accident (CVA), drowning, smoke inhalation, electrocution, hanging
  • Already hypothermic
  • Head trauma
  • Cannot place intra nasal catheters
  • Do Not Attempt to Resuscitate (DNAR) orders
  • Known or clinically apparent pregnancy
  • Have a known coagulopathy (except therapeutically induced)
  • Are known to have a need for supplemental oxygen
  • Achieve return of spontaneous circulation (ROSC) prior to initiating cooling
  • Are reached by emergency medical services (EMS) personnel more than 20 minutes after collapse

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

200 participants in 2 patient groups

RhinoChill
Experimental group
Description:
Intra-arrest cooling with the RhinoChill during advanced cardiac life support
Treatment:
Device: RhinoChill
Control
Other group
Description:
Advanced cardiac life support, only
Treatment:
Other: Control

Trial contacts and locations

15

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems